Global Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
According to APO Research, The global Active Pharmaceutical Ingredients (API) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
In terms of production side, this report researches the Active Pharmaceutical Ingredients (API) production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Active Pharmaceutical Ingredients (API) by region (region level and country level), by company, by type and by application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Active Pharmaceutical Ingredients (API), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Active Pharmaceutical Ingredients (API), also provides the consumption of main regions and countries. Of the upcoming market potential for Active Pharmaceutical Ingredients (API), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Active Pharmaceutical Ingredients (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Active Pharmaceutical Ingredients (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Active Pharmaceutical Ingredients (API) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer and Huahai Pharmaceutical, etc.
Active Pharmaceutical Ingredients (API) segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Pharmaceutical Ingredients (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Active Pharmaceutical Ingredients (API) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Active Pharmaceutical Ingredients (API) industry.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) market competition landscape. Including Active Pharmaceutical Ingredients (API) manufacturers' output value, output and average price from 2019 to 2024, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Active Pharmaceutical Ingredients (API) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
According to APO Research, The global Active Pharmaceutical Ingredients (API) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
In terms of production side, this report researches the Active Pharmaceutical Ingredients (API) production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Active Pharmaceutical Ingredients (API) by region (region level and country level), by company, by type and by application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Active Pharmaceutical Ingredients (API), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Active Pharmaceutical Ingredients (API), also provides the consumption of main regions and countries. Of the upcoming market potential for Active Pharmaceutical Ingredients (API), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Active Pharmaceutical Ingredients (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Active Pharmaceutical Ingredients (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Active Pharmaceutical Ingredients (API) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer and Huahai Pharmaceutical, etc.
Active Pharmaceutical Ingredients (API) segment by Company
- Teva
- Mylan
- DSM
- Aurobindo Pharma
- Aspen
- Novartis
- BASF
- Pfizer
- Huahai Pharmaceutical
- Hisun Pharmaceutical
- Sun Pharmaceutical Industries
- Zhejiang Medicine
- Dr. Reddy’s Laboratories
- Zhejiang NHU
- Bayer
- NCPC
- AbbVie
- Shandong Xinhua Pharmaceutical
- Northeast Pharm
- Harbin Pharmaceutical
- LKPC
- Synthetic APIs
- Biotech APIs
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Pharmaceutical Ingredients (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Active Pharmaceutical Ingredients (API) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Active Pharmaceutical Ingredients (API) industry.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) market competition landscape. Including Active Pharmaceutical Ingredients (API) manufacturers' output value, output and average price from 2019 to 2024, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Active Pharmaceutical Ingredients (API) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
1.2.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2019-2030)
1.2.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2019-2030)
1.2.4 Global Active Pharmaceutical Ingredients (API) Market Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET DYNAMICS
2.1 Active Pharmaceutical Ingredients (API) Industry Trends
2.2 Active Pharmaceutical Ingredients (API) Industry Drivers
2.3 Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
2.4 Active Pharmaceutical Ingredients (API) Industry Restraints
3 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY MANUFACTURERS
3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2019-2024)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2019-2024)
3.4 Global Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
3.7 Global Active Pharmaceutical Ingredients (API) Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Active Pharmaceutical Ingredients (API) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Active Pharmaceutical Ingredients (API) Players Market Share by Production Value in 2023
3.8.3 2023 Active Pharmaceutical Ingredients (API) Tier 1, Tier 2, and Tier
4 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY TYPE
4.1 Active Pharmaceutical Ingredients (API) Type Introduction
4.1.1 Synthetic APIs
4.1.2 Biotech APIs
4.2 Global Active Pharmaceutical Ingredients (API) Production by Type
4.2.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019 VS 2023 VS 2030)
4.2.2 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030)
4.2.3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2030)
4.3 Global Active Pharmaceutical Ingredients (API) Production Value by Type
4.3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030)
4.3.3 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2030)
5 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY APPLICATION
5.1 Active Pharmaceutical Ingredients (API) Application Introduction
5.1.1 CNS
5.1.2 Cardiovascular
5.1.3 Genitourinary/Hormonal Drugs
5.1.4 Respiratory
5.1.5 Rheumatology
5.1.6 Diabetes
5.1.7 Oncology
5.1.8 Others
5.2 Global Active Pharmaceutical Ingredients (API) Production by Application
5.2.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019 VS 2023 VS 2030)
5.2.2 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030)
5.2.3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Application (2019-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Production Value by Application
5.3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030)
5.3.3 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Teva
6.1.1 Teva Comapny Information
6.1.2 Teva Business Overview
6.1.3 Teva Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.1.4 Teva Active Pharmaceutical Ingredients (API) Product Portfolio
6.1.5 Teva Recent Developments
6.2 Mylan
6.2.1 Mylan Comapny Information
6.2.2 Mylan Business Overview
6.2.3 Mylan Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Portfolio
6.2.5 Mylan Recent Developments
6.3 DSM
6.3.1 DSM Comapny Information
6.3.2 DSM Business Overview
6.3.3 DSM Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.3.4 DSM Active Pharmaceutical Ingredients (API) Product Portfolio
6.3.5 DSM Recent Developments
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Comapny Information
6.4.2 Aurobindo Pharma Business Overview
6.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments
6.5 Aspen
6.5.1 Aspen Comapny Information
6.5.2 Aspen Business Overview
6.5.3 Aspen Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Portfolio
6.5.5 Aspen Recent Developments
6.6 Novartis
6.6.1 Novartis Comapny Information
6.6.2 Novartis Business Overview
6.6.3 Novartis Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Portfolio
6.6.5 Novartis Recent Developments
6.7 BASF
6.7.1 BASF Comapny Information
6.7.2 BASF Business Overview
6.7.3 BASF Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.7.4 BASF Active Pharmaceutical Ingredients (API) Product Portfolio
6.7.5 BASF Recent Developments
6.8 Pfizer
6.8.1 Pfizer Comapny Information
6.8.2 Pfizer Business Overview
6.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Portfolio
6.8.5 Pfizer Recent Developments
6.9 Huahai Pharmaceutical
6.9.1 Huahai Pharmaceutical Comapny Information
6.9.2 Huahai Pharmaceutical Business Overview
6.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.9.5 Huahai Pharmaceutical Recent Developments
6.10 Hisun Pharmaceutical
6.10.1 Hisun Pharmaceutical Comapny Information
6.10.2 Hisun Pharmaceutical Business Overview
6.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.10.5 Hisun Pharmaceutical Recent Developments
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Comapny Information
6.11.2 Sun Pharmaceutical Industries Business Overview
6.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments
6.12 Zhejiang Medicine
6.12.1 Zhejiang Medicine Comapny Information
6.12.2 Zhejiang Medicine Business Overview
6.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Portfolio
6.12.5 Zhejiang Medicine Recent Developments
6.13 Dr. Reddy’s Laboratories
6.13.1 Dr. Reddy’s Laboratories Comapny Information
6.13.2 Dr. Reddy’s Laboratories Business Overview
6.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Portfolio
6.13.5 Dr. Reddy’s Laboratories Recent Developments
6.14 Zhejiang NHU
6.14.1 Zhejiang NHU Comapny Information
6.14.2 Zhejiang NHU Business Overview
6.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Portfolio
6.14.5 Zhejiang NHU Recent Developments
6.15 Bayer
6.15.1 Bayer Comapny Information
6.15.2 Bayer Business Overview
6.15.3 Bayer Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Portfolio
6.15.5 Bayer Recent Developments
6.16 NCPC
6.16.1 NCPC Comapny Information
6.16.2 NCPC Business Overview
6.16.3 NCPC Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Portfolio
6.16.5 NCPC Recent Developments
6.17 AbbVie
6.17.1 AbbVie Comapny Information
6.17.2 AbbVie Business Overview
6.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Portfolio
6.17.5 AbbVie Recent Developments
6.18 Shandong Xinhua Pharmaceutical
6.18.1 Shandong Xinhua Pharmaceutical Comapny Information
6.18.2 Shandong Xinhua Pharmaceutical Business Overview
6.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.18.5 Shandong Xinhua Pharmaceutical Recent Developments
6.19 Northeast Pharm
6.19.1 Northeast Pharm Comapny Information
6.19.2 Northeast Pharm Business Overview
6.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Portfolio
6.19.5 Northeast Pharm Recent Developments
6.20 Harbin Pharmaceutical
6.20.1 Harbin Pharmaceutical Comapny Information
6.20.2 Harbin Pharmaceutical Business Overview
6.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.20.5 Harbin Pharmaceutical Recent Developments
6.21 LKPC
6.21.1 LKPC Comapny Information
6.21.2 LKPC Business Overview
6.21.3 LKPC Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Portfolio
6.21.5 LKPC Recent Developments
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) PRODUCTION BY REGION
7.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030
7.2 Global Active Pharmaceutical Ingredients (API) Production by Region (2019-2030)
7.2.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2024
7.2.2 Global Active Pharmaceutical Ingredients (API) Production by Region (2025-2030)
7.3 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030
7.4 Global Active Pharmaceutical Ingredients (API) Production Value by Region (2019-2030)
7.4.1 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2024
7.4.2 Global Active Pharmaceutical Ingredients (API) Production Value by Region (2025-2030)
7.5 Global Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2019-2024)
7.6 Regional Production Value Trends (2019-2030)
7.6.1 North America Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.2 Europe Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.4 Latin America Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CONSUMPTION BY REGION
8.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region: 2019 VS 2023 VS 2030
8.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)
8.2.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2024)
8.2.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2025-2030)
8.3 North America
8.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.3.2 North America Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.3.3 U.S.
8.3.4 Canada
8.4 Europe
8.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.4.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.5.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 LAMEA
8.6.1 LAMEA Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.6.2 LAMEA Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.6.3 Mexico
8.6.4 Brazil
8.6.5 Turkey
8.6.6 GCC Countries
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
9.1.1 Active Pharmaceutical Ingredients (API) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Active Pharmaceutical Ingredients (API) Production Mode & Process
9.2 Active Pharmaceutical Ingredients (API) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Active Pharmaceutical Ingredients (API) Distributors
9.2.3 Active Pharmaceutical Ingredients (API) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
1.2.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2019-2030)
1.2.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2019-2030)
1.2.4 Global Active Pharmaceutical Ingredients (API) Market Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET DYNAMICS
2.1 Active Pharmaceutical Ingredients (API) Industry Trends
2.2 Active Pharmaceutical Ingredients (API) Industry Drivers
2.3 Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
2.4 Active Pharmaceutical Ingredients (API) Industry Restraints
3 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY MANUFACTURERS
3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2019-2024)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2019-2024)
3.4 Global Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
3.7 Global Active Pharmaceutical Ingredients (API) Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Active Pharmaceutical Ingredients (API) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Active Pharmaceutical Ingredients (API) Players Market Share by Production Value in 2023
3.8.3 2023 Active Pharmaceutical Ingredients (API) Tier 1, Tier 2, and Tier
4 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY TYPE
4.1 Active Pharmaceutical Ingredients (API) Type Introduction
4.1.1 Synthetic APIs
4.1.2 Biotech APIs
4.2 Global Active Pharmaceutical Ingredients (API) Production by Type
4.2.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019 VS 2023 VS 2030)
4.2.2 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030)
4.2.3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2030)
4.3 Global Active Pharmaceutical Ingredients (API) Production Value by Type
4.3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030)
4.3.3 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2030)
5 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY APPLICATION
5.1 Active Pharmaceutical Ingredients (API) Application Introduction
5.1.1 CNS
5.1.2 Cardiovascular
5.1.3 Genitourinary/Hormonal Drugs
5.1.4 Respiratory
5.1.5 Rheumatology
5.1.6 Diabetes
5.1.7 Oncology
5.1.8 Others
5.2 Global Active Pharmaceutical Ingredients (API) Production by Application
5.2.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019 VS 2023 VS 2030)
5.2.2 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030)
5.2.3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Application (2019-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Production Value by Application
5.3.1 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030)
5.3.3 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Teva
6.1.1 Teva Comapny Information
6.1.2 Teva Business Overview
6.1.3 Teva Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.1.4 Teva Active Pharmaceutical Ingredients (API) Product Portfolio
6.1.5 Teva Recent Developments
6.2 Mylan
6.2.1 Mylan Comapny Information
6.2.2 Mylan Business Overview
6.2.3 Mylan Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Portfolio
6.2.5 Mylan Recent Developments
6.3 DSM
6.3.1 DSM Comapny Information
6.3.2 DSM Business Overview
6.3.3 DSM Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.3.4 DSM Active Pharmaceutical Ingredients (API) Product Portfolio
6.3.5 DSM Recent Developments
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Comapny Information
6.4.2 Aurobindo Pharma Business Overview
6.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments
6.5 Aspen
6.5.1 Aspen Comapny Information
6.5.2 Aspen Business Overview
6.5.3 Aspen Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Portfolio
6.5.5 Aspen Recent Developments
6.6 Novartis
6.6.1 Novartis Comapny Information
6.6.2 Novartis Business Overview
6.6.3 Novartis Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Portfolio
6.6.5 Novartis Recent Developments
6.7 BASF
6.7.1 BASF Comapny Information
6.7.2 BASF Business Overview
6.7.3 BASF Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.7.4 BASF Active Pharmaceutical Ingredients (API) Product Portfolio
6.7.5 BASF Recent Developments
6.8 Pfizer
6.8.1 Pfizer Comapny Information
6.8.2 Pfizer Business Overview
6.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Portfolio
6.8.5 Pfizer Recent Developments
6.9 Huahai Pharmaceutical
6.9.1 Huahai Pharmaceutical Comapny Information
6.9.2 Huahai Pharmaceutical Business Overview
6.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.9.5 Huahai Pharmaceutical Recent Developments
6.10 Hisun Pharmaceutical
6.10.1 Hisun Pharmaceutical Comapny Information
6.10.2 Hisun Pharmaceutical Business Overview
6.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.10.5 Hisun Pharmaceutical Recent Developments
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Comapny Information
6.11.2 Sun Pharmaceutical Industries Business Overview
6.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments
6.12 Zhejiang Medicine
6.12.1 Zhejiang Medicine Comapny Information
6.12.2 Zhejiang Medicine Business Overview
6.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Portfolio
6.12.5 Zhejiang Medicine Recent Developments
6.13 Dr. Reddy’s Laboratories
6.13.1 Dr. Reddy’s Laboratories Comapny Information
6.13.2 Dr. Reddy’s Laboratories Business Overview
6.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Portfolio
6.13.5 Dr. Reddy’s Laboratories Recent Developments
6.14 Zhejiang NHU
6.14.1 Zhejiang NHU Comapny Information
6.14.2 Zhejiang NHU Business Overview
6.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Portfolio
6.14.5 Zhejiang NHU Recent Developments
6.15 Bayer
6.15.1 Bayer Comapny Information
6.15.2 Bayer Business Overview
6.15.3 Bayer Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Portfolio
6.15.5 Bayer Recent Developments
6.16 NCPC
6.16.1 NCPC Comapny Information
6.16.2 NCPC Business Overview
6.16.3 NCPC Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Portfolio
6.16.5 NCPC Recent Developments
6.17 AbbVie
6.17.1 AbbVie Comapny Information
6.17.2 AbbVie Business Overview
6.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Portfolio
6.17.5 AbbVie Recent Developments
6.18 Shandong Xinhua Pharmaceutical
6.18.1 Shandong Xinhua Pharmaceutical Comapny Information
6.18.2 Shandong Xinhua Pharmaceutical Business Overview
6.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.18.5 Shandong Xinhua Pharmaceutical Recent Developments
6.19 Northeast Pharm
6.19.1 Northeast Pharm Comapny Information
6.19.2 Northeast Pharm Business Overview
6.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Portfolio
6.19.5 Northeast Pharm Recent Developments
6.20 Harbin Pharmaceutical
6.20.1 Harbin Pharmaceutical Comapny Information
6.20.2 Harbin Pharmaceutical Business Overview
6.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
6.20.5 Harbin Pharmaceutical Recent Developments
6.21 LKPC
6.21.1 LKPC Comapny Information
6.21.2 LKPC Business Overview
6.21.3 LKPC Active Pharmaceutical Ingredients (API) Production, Value and Gross Margin (2019-2024)
6.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Portfolio
6.21.5 LKPC Recent Developments
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) PRODUCTION BY REGION
7.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030
7.2 Global Active Pharmaceutical Ingredients (API) Production by Region (2019-2030)
7.2.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2024
7.2.2 Global Active Pharmaceutical Ingredients (API) Production by Region (2025-2030)
7.3 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019 VS 2023 VS 2030
7.4 Global Active Pharmaceutical Ingredients (API) Production Value by Region (2019-2030)
7.4.1 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2024
7.4.2 Global Active Pharmaceutical Ingredients (API) Production Value by Region (2025-2030)
7.5 Global Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2019-2024)
7.6 Regional Production Value Trends (2019-2030)
7.6.1 North America Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.2 Europe Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.4 Latin America Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
7.6.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Production Value (2019-2030)
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CONSUMPTION BY REGION
8.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region: 2019 VS 2023 VS 2030
8.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)
8.2.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2024)
8.2.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2025-2030)
8.3 North America
8.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.3.2 North America Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.3.3 U.S.
8.3.4 Canada
8.4 Europe
8.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.4.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.5.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 LAMEA
8.6.1 LAMEA Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.6.2 LAMEA Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
8.6.3 Mexico
8.6.4 Brazil
8.6.5 Turkey
8.6.6 GCC Countries
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
9.1.1 Active Pharmaceutical Ingredients (API) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Active Pharmaceutical Ingredients (API) Production Mode & Process
9.2 Active Pharmaceutical Ingredients (API) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Active Pharmaceutical Ingredients (API) Distributors
9.2.3 Active Pharmaceutical Ingredients (API) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
